Lirimilast

Lirimilast (BAY 19-8004; BAY 198004) is a potent and selective PDE4 inhibitor for the treatment of COPD.

329306-27-6

≥ 2 years

>98% (HPLC)

443.251

C17H12Cl2N2O6S

Research use only, not for human use.

PDE

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

ELA-E1804h 96 Tests

Ask

bsm-61110R-BF555-01 20 µL

Ask

bsm-61110R-BF555-02 100 µL

Ask

NBP2-72067FR 0.1 mL

Ask

HY-N0746-01 5 mg

Ask

HY-N0746-02 10 mg

Ask